# Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid

> **NCT00731016** · PHASE2 · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 15 (actual)

## Conditions studied

- Hutchinson-Gilford Progeria Syndrome

## Interventions

- **DRUG:** Zoledronic acid, pravastatin

## Key facts

- **NCT ID:** NCT00731016
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2013-04
- **Final completion:** 2013-07
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00731016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00731016, "Treatment of the Hutchinson-Gilford Progeria Syndrome With a Combination of Pravastatin and Zoledronic Acid". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00731016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*